Shares of Fusion Antibodies plc (LON:FAB – Get Free Report) traded up 3.9% during trading on Tuesday . The stock traded as high as GBX 6.50 ($0.08) and last traded at GBX 6.39 ($0.08). 2,294,034 shares were traded during trading, an increase of 73% from the average session volume of 1,327,368 shares. The stock had previously closed at GBX 6.15 ($0.08).
Fusion Antibodies Stock Performance
The company has a debt-to-equity ratio of 2.40, a quick ratio of 2.36 and a current ratio of 3.87. The company has a market cap of £6.01 million, a PE ratio of -1.44 and a beta of 0.49. The business’s 50-day moving average is GBX 7.70 and its 200 day moving average is GBX 6.26.
About Fusion Antibodies
The Company’s ordinary shares were admitted to trading on AIM on 18 December 2017. Fusion provides a broad range of services in antibody generation, development, production, characterisation and optimisation.
Featured Stories
- Five stocks we like better than Fusion Antibodies
- Basic Materials Stocks Investing
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- Quiet Period Expirations Explained
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Buffett Trims Equities, But Still Keeps Buying This Stock
Receive News & Ratings for Fusion Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fusion Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
